ONMD vs POM
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
The company exhibits critical financial distress, highlighted by a Piotroski F-Score of 0/9, indicating the weakest possible financial health. With a negative Price-to-Book ratio of -15.47 and a Current Ratio of 0.43, ONMD is facing a severe liquidity crisis and possesses negative shareholder equity. While the reported revenue growth of 3326.90% is astronomical, it is offset by a negative gross margin (-37.01%) and massive operating losses, suggesting that growth is currently being achieved at an unsustainable cost. The combination of bearish insider activity and a total lack of profitability makes this a high-risk speculative asset.
Pomdoctor Limited exhibits severe financial distress, anchored by a weak Piotroski F-Score of 3/9 and a catastrophic liquidity profile. With a Current Ratio of 0.17 and a negative Price-to-Book ratio (-0.04), the company is effectively insolvent and unable to meet its short-term obligations. Despite a modest 16.2% revenue growth, the stock has collapsed by over 90% across all major timeframes, signaling a complete loss of investor confidence and high bankruptcy risk.
Compare Another Pair
Related Comparisons
ONMD vs POM: Head-to-Head Comparison
This page compares OneMedNet Corporation (ONMD) and Pomdoctor Limited (POM) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.